
3.04 Delayed Data As of Sep 29 | ![]() Today’s Change | 2.79 Today|||52-Week Range 30.10 | -79.21% Year-to-Date |
Bionano Genomics, Inc. (BNGO) Upgraded to Buy: Here's What You Should Know Sep 21 / Zacks.com - Paid Partner Content |
Previous close | 2.90 |
Today’s open | 2.97 |
Day’s range | 2.95 - 3.07 |
Volume | 16,412 |
Average volume (3 months) | 1,018,391 |
Market cap | $107.1M |
Earnings growth (last year) | -75.19% |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +54.62% |
P/E ratio | NM |
Price/Sales | 15.19 |
Price/Book | 0.36 |
Today’s change | Today’s % change | |
---|---|---|
ARMPArmata Pharmaceutica... | +0.05 | +1.77% |
CUECue Biopharma Inc | -0.03 | -1.29% |
OCGNOcugen Inc | +0.00 | +0.99% |
ANIXAnixa Biosciences In... | +0.06 | +1.87% |
Next reporting date | November 9, 2023 |
EPS forecast (this quarter) | -$0.09 |
Annual revenue (last year) | $27.8M |
Annual profit (last year) | -$132.6M |
Net profit margin | -476.93% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |